A detailed history of Intech Investment Management LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 56,052 shares of SMMT stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,052
Previous 31,680 76.93%
Holding current value
$1.08 Million
Previous $693,000 44.3%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$17.52 - $23.46 $426,997 - $571,767
24,372 Added 76.93%
56,052 $1 Million
Q3 2024

Nov 08, 2024

BUY
$6.89 - $31.93 $218,275 - $1.01 Million
31,680 New
31,680 $693,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.87B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.